Recent Finacing
Recent Raise
BAKX Therapeutics develops structure-based and computational small-molecule activators of pro-apoptotic BAX/BAK, advancing BKX-001 and a BAKX Activator Program toward clinical trials for hematologic and solid tumors.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at BAKX Therapeutics.
